Trends in the sequence of first alcohol, cannabis and cigarette use in Australia, 2001-2016.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 09 09 2019
revised: 08 12 2019
accepted: 11 12 2019
pubmed: 14 1 2020
medline: 20 11 2020
entrez: 14 1 2020
Statut: ppublish

Résumé

Recent analyses of data from the US found that young people were increasingly engaging in cannabis use before alcohol and cigarettes. These shifts are important for public health, but it is not clear whether such trends extend beyond the US. The aim of this study is to examine whether and how the age and sequencing of initiation into alcohol, cannabis and cigarette use has changed in Australia since the early 2000s. Data came from six waves of the Australian National Drug Strategy Household Survey, spanning 2001-2016. We used data from 18 to 21 year-olds (n = 6849) and examined trends in the age at first use for each of the three substances plus any changes in the order of initiation. The mean age of initiation increased steadily for all three substances (e.g. from 14.9 in 2001 to 16.4 in 2016 for alcohol), while the prevalence of any use declined. There were some changes in ordering of use. For example, in 2001, 62 % of respondents who used both cigarettes and cannabis had first used cigarettes at an earlier age than cannabis, compared with 41 % in 2016. Young people who used both alcohol and cannabis remained more likely to try alcohol before cannabis across the study period. Our results partly replicated US findings, with differences potentially reflecting the substantially different environment around these substances in the US compared to Australia. The age of initiation for alcohol, cigarette and cannabis use in Australia has increased sharply over the past 15 years.

Sections du résumé

BACKGROUND
Recent analyses of data from the US found that young people were increasingly engaging in cannabis use before alcohol and cigarettes. These shifts are important for public health, but it is not clear whether such trends extend beyond the US. The aim of this study is to examine whether and how the age and sequencing of initiation into alcohol, cannabis and cigarette use has changed in Australia since the early 2000s.
METHODS
Data came from six waves of the Australian National Drug Strategy Household Survey, spanning 2001-2016. We used data from 18 to 21 year-olds (n = 6849) and examined trends in the age at first use for each of the three substances plus any changes in the order of initiation.
RESULTS
The mean age of initiation increased steadily for all three substances (e.g. from 14.9 in 2001 to 16.4 in 2016 for alcohol), while the prevalence of any use declined. There were some changes in ordering of use. For example, in 2001, 62 % of respondents who used both cigarettes and cannabis had first used cigarettes at an earlier age than cannabis, compared with 41 % in 2016. Young people who used both alcohol and cannabis remained more likely to try alcohol before cannabis across the study period.
CONCLUSIONS
Our results partly replicated US findings, with differences potentially reflecting the substantially different environment around these substances in the US compared to Australia. The age of initiation for alcohol, cigarette and cannabis use in Australia has increased sharply over the past 15 years.

Identifiants

pubmed: 31927161
pii: S0376-8716(19)30598-8
doi: 10.1016/j.drugalcdep.2019.107821
pmc: PMC7614940
mid: EMS184779
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107821

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208090/Z/17/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Drug Alcohol Rev. 2015 Mar;34(2):115-8
pubmed: 25756218
J Sch Health. 2016 Jan;86(1):31-8
pubmed: 26645418
Drug Alcohol Depend. 2010 Apr 1;108(1-2):84-97
pubmed: 20060657
Tob Control. 2020 Jan;29(1):49-54
pubmed: 30498008
Recent Dev Alcohol. 2005;17:29-47
pubmed: 15789858
Lancet Psychiatry. 2016 Mar;3(3):251-64
pubmed: 26905480
Tob Control. 2008 Feb;17(1):25-31
pubmed: 18218803
Alcohol Clin Exp Res. 2001 Aug;25(8):1156-65
pubmed: 11505047
Drug Alcohol Rev. 2017 Sep;36(5):602-608
pubmed: 28439990
Aust N Z J Public Health. 2016 Jun;40(3):233-5
pubmed: 27028197
Drug Alcohol Depend. 2019 Jan 1;194:51-58
pubmed: 30399500
Alcohol Clin Exp Res. 2011 Aug;35(8):1418-25
pubmed: 21438885
Addiction. 2018 Jul;113(7):1317-1332
pubmed: 29484751
Prev Med. 2017 Nov;104:13-23
pubmed: 28705601
J Subst Abuse. 1997;9:103-10
pubmed: 9494942
Addiction. 2008 May;103 Suppl 1:23-35
pubmed: 18426538
Addiction. 2005 May;100(5):652-61
pubmed: 15847623
Med J Aust. 2016 Jun 6;204(10):371-3
pubmed: 27256646
Nicotine Tob Res. 2015 Oct;17(10):1203-11
pubmed: 25358657
Addict Behav. 1997 Sep-Oct;22(5):613-23
pubmed: 9347063
Eur J Public Health. 2015 Apr;25 Suppl 2:69-72
pubmed: 25805792
Prev Med. 2004 Nov;39(5):976-84
pubmed: 15475032
Addiction. 2004 Oct;99(10):1333-41
pubmed: 15369572
Addiction. 2014 Jun;109(6):922-9
pubmed: 24717214
Prev Sci. 2019 Feb;20(2):225-233
pubmed: 29770947
Tob Control. 2015 Apr;24(Suppl 2):ii3-ii8
pubmed: 28407604
J Stud Alcohol Drugs. 2017 Nov;78(6):844-852
pubmed: 29087818

Auteurs

Michael Livingston (M)

Centre for Alcohol Policy Research, La Trobe University, Melbourne, Australia; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Electronic address: m.livingston@latrobe.edu.au.

John Holmes (J)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Melissa Oldham (M)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Rakhi Vashishtha (R)

Centre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.

Amy Pennay (A)

Centre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH